{
    "title": "Individual feed for https://fortune.com/feed/fortune-feeds/?id=3230629",
    "link": "https://fortune.com/feed/fortune-feeds/?id=3230629",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-02-05T11:04:33.928816",
    "items": [
        {
            "title": "Patients will pay more for prescription meds and face drug shortages amid Trump tariffs, pharma groups warn",
            "link": "https://fortune.com/well/article/trump-import-tariffs-china-canada-mexico-pharma-prescription-drug-costs-shortages/",
            "description": "China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients.",
            "pubDate": "2025-02-05T15:55:36",
            "image_url": "https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-2169115963-e1738688135162.jpg?w=2048"
        },
        {
            "title": "Novo Nordisk missed its diversity targets last year, and its CEO paid a financial price",
            "link": "https://fortune.com/europe/2025/02/05/novo-nordisk-missed-dei-targets-last-year-ceo-paid-financial-price/",
            "description": "Novo Nordisk's CEO took a $1.5 million pay cut in 2024 as the pharma giant's share price tanked and it missed profit and DEI targets.",
            "pubDate": "2025-02-05T15:48:52",
            "image_url": "https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-2174206073-e1738766467341.jpg?w=2048"
        },
        {
            "title": "Farewell, quiet quitting. 2025 could be the year of ‘revenge quitting’",
            "link": "https://fortune.com/2025/02/05/revenge-quitting-2025/",
            "description": "Worker dissatisfaction could lead to a revolt.",
            "pubDate": "2025-02-05T15:48:50",
            "image_url": "https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-1381437080-e1738769294224.jpg?w=2048"
        },
        {
            "title": "Amid a global loss of trust, institutions must prove their value, says Edelman’s CEO",
            "link": "https://fortune.com/2025/02/05/amid-a-global-loss-of-trust-institutions-must-prove-their-value-says-edelmans-ceo/",
            "description": "What institutions do Americans trust the most? Businesses, according to the latest Edelman Trust Barometer.",
            "pubDate": "2025-02-05T15:46:19",
            "image_url": "https://fortune.com/img-assets/wp-content/uploads/2025/02/Leadership_Next_Richard-Edelman.jpg?w=2048"
        },
        {
            "title": "Elon Musk says he will be irreparably harmed if OpenAI isn’t stopped. The federal judge overseeing his lawsuit called it a ‘stretch’",
            "link": "https://fortune.com/2025/02/05/elon-musk-openai-sam-altman-lawsuit-judge-yvonne-gonzalez-rogers/",
            "description": "At the heart of the dispute is a 2017 internal power struggle at the fledgling startup that led to Altman becoming OpenAI’s CEO.",
            "pubDate": "2025-02-05T15:44:42",
            "image_url": "https://fortune.com/img-assets/wp-content/uploads/2025/02/AP25020586540582-e1738770209448.jpg?w=2048"
        }
    ]
}